Randomized phase III study: Pembrolizumab in HCC patients
This Medudy course is a video tutorial for physicians on the topic of "Pembrolizumab in HCC patients". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. HCC patients are often diagnosed late with advanced hepatocellular carcinoma, when curative approaches are no longer possible [...].
A randomized controlled trial: Bivalirudin vs. heparin in STEMI-PCI patients
This medudy course is a video tutorial for physicians on the topic "Treatment of patients with STEMI after PCI", in which we summarize the latest and most important clinical studies for you. Unfractionated heparin and bivalirudin are commonly used anticoagulants in primary PCI, with bivalirudin showing a promising reduction in bleeding and bleeding risk compared to heparin in previous studies.